@Eyecelerator

Founded by the American Academy of Ophthalmology and ASCRS, Eyecelerator is today’s most powerful and forward-thinking innovation meeting.

eyecelerator.com/
Joined February 2020
  • Tweets466
  • Following89
  • Followers612
294Media
Neurotech's Executive Chairman, Jim Mazzo debut's a new program at Eyecelerator @ ASCRS 2023. The "Eyecelerator Company Case Study" featuring Glaukos, Profiles in Courage. #neurotech #ophthalmology #retina #mactel #eyecelerator #ASCRS2023
1
3
176
Panelists join moderator @LizYeu for @Eyecelerator's "If you're not first, you're last: First-in-human studies" session. #eyecelerator
2
2
382
Jim Mazzo kicks off this afternoon's @Eyecelerator company case study session on Glaukos. #Eyecelerator
2
5
394
“We need more giraffes!” — @JohnBerdahl complimenting the finalists of the Winning Pitch Challenge @Eyecelerator — physicians willing to stick their necks out to bring forward innovations for the benefit of patients. @ASCRStweets – at San Diego, CA
1
1
5
348
To kick off this morning's @Eyecelerator program, @JohnBerdahl and Julie Schallhorn, MD, give an overview of the day's agenda. #eyecelerator
2
7
1,049
It’s a full house at @Eyecelerator 2023.
1
2
515
“Things are happening faster and have greater implications.” - Gil Kliman, MD @Eyecelerator #eyecelerator
1
1
280
Steve Spears, executive director of the @ASCRSFoundation, kicks off this year’s @Eyecelerator program. #Eyecelerator
1
2
303
We are riding the wave into town for #ASCRS2023. Be on the LOOK out for members of our team in attendance at the conference and as sponsors for #Eyecelerator and the Holland Foundation’s Eye Love Rock N’ Roll event! #Ophthalmology
1
115
#VisusTx is delighted to present key positive topline data from the Phase 3 pivotal BRIO-I trial of BRIMOCHOL™ PF the treatment of #Presbyopia at today’s @Eyecelerator meeting @ASCRStweets. Learn more via the full press release: businesswire.com/news/home/2…

Visus Therapeutics Presents Topline Clinical Data from Phase 3 Pivotal BRIO-I Trial of BRIMOCHOL™...

Visus Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing multi-targeted ophthalmic therapies for indications in the front an...

businesswire.com
1
1
3
205
Eyecelerator retweeted
ASCRS@ASCRStweets4 May 2023
The Eyecelerator meeting, a partnership between ASCRS and AAO, takes place today at the Marriott Marquis San Diego Marina. Looking forward to lots of innovation and inspiration! #Eyecelerator #ASCRS2023 #Future #Innovation #Ophthalmology #Entrepreneurs
1
2
497
Eyecelerator retweeted
OcuTerra@OcuTerra3 Oct 2022
Thank you to AAO @aao_ophth and the American Society of Cataract and Refractive Surgery @ASCRStweets for hosting this year's @Eyecelerator and #AAO2022. We enjoyed connecting with leaders bringing the future of #ophthalmology into focus at the world's largest ophthalmic expo.
1
3
IRIS Registry: 11% of patients with wet AMD lost to follow-up. healio.com/news/ophthalmolog… @Eyecelerator #Eyecelerator #AAO2022 @aao_ophth #Ophthalmology #OncularNews #MedTwitter
1
1
California governor vetoes expanded scope for optometrists. healio.com/news/ophthalmolog… @Eyecelerator #Eyecelerator #AAO2022 @aao_ophth #selectivelasertrabeculoplasty #Opthalmology #OcularNews #MedTwitter @ASCRStweets

California governor vetoes expanded scope for optometrists

CHICAGO — California Gov. Gavin Newsom vetoed a bill that would have allowed optometrists in the state to use therapeutic lasers and perform other procedures.

healio.com
1
2
WATCH: @Opthea CEO discusses updates on OPT-302 for treatment of wet AMD. healio.com/news/ophthalmolog… #maculardegeneration #ophthalmicbusiness #Ophthalmology #OncularNews @Eyecelerator #Eyecelerator #AAO2022 @aao_ophth #MedTwitter @ASCRStweets @OptheaLimited
1
2
Vance Thompson, MD, kicks off the @Eyecelerator Winning Pitch Challenge at #AAO2022. @vthompsonvision 🥊
1
4
StepWise Medical CEO Vartan Ghazarossian, PhD said when looking at where to invest: I look at the team first, the market second and the product last. #eyecelerator @aao_ophth @Eyecelerator – at Chicago, IL
1
2
Replying to @ZainaAlMohtaseb
@ZainaAlMohtaseb at @Eyecelerator: Ophthalmologists continue to demonstrate a lot of excitement for #presbyopia treatment. #aao2022 #eyecelerator – at Chicago, IL
1
5
Replying to @SamGargMD
@SamGargMD: We need Vuity to succeed to move the field forward. #aao2022 @Eyecelerator #eyecelerator #presbyopia – at Chicago, IL
1
5
Patient voice is critical to developing endpoints for clinical trials, says Malvina B. Eydelman, MD, of the @US_FDA at #Eyecelerator at #AAO2022
1
3
Load more